DNA vaccine against hamster oral papillomavirus-associated oral cancer.
Previously we developed a carcinogenesis model involving the combination of 9,10-dimethyl-1,2-benzanthracene (DMBA) application with physical wounding of hamster lingual mucosa. The presence of a novel hamster oral papillomavirus (HOPV) was demonstrated and its genome sequenced. In the present study, this HOPV hamster model was used to test whether vaccination with the L1 gene could prevent the development of oral carcinoma. DNA plasmids encoding the L1 gene or the vector alone were injected intramuscularly into 20 vaccinated and 20 control hamsters, respectively. The lingual tips of the hamsters were painted with DMBA for 8 weeks. A portion of the lingual tips was excised, and the tips were then painted daily with DMBA until the animals were killed 13 days later. All control hamsters developed lingual carcinoma, whereas 12 of the L1-vaccinated hamsters showed no lesions. These results suggest that immunization with L1 DNA vaccines may prevent the development of papillomavirus-associated oral cancer.
Maeda
H
H
Department of Pathology, School of Dentistry, Aichi-Gakuin University, Nagoya, Japan. hatsu@dpc.aichi-gakuin.ac.jp
Kubo
K
K
Sugita
Y
Y
Miyamoto
Y
Y
Komatsu
S
S
Takeuchi
S
S
Umebayashi
T
T
Morikawa
S
S
Kawanishi
K
K
Kameyama
Y
Y
D015127:9,10-Dimethyl-1,2-benzanthracene / Q000633:toxicity; D000818:Animals; D036022:Capsid Proteins; D006224:Cricetinae; D004195:Disease Models, Animal; D008297:Male; D008647:Mesocricetus; D009062:Mouth Neoplasms / Q000139:chemically induced / Q000473:pathology / Q000517:prevention & control*; D009856:Oncogene Proteins, Viral / Q000235:genetics; D030361:Papillomavirus Infections / Q000150:complications / Q000473:pathology / Q000517:prevention & control*; D019444:Vaccines, DNA / Q000235:genetics / Q000494:pharmacology*
D036022:Capsid Proteins; C114580:HPV L1 protein, Human papillomavirus; D009856:Oncogene Proteins, Viral; D019444:Vaccines, DNA; D015127:9,10-Dimethyl-1,2-benzanthracene